Close

Drug Research

OBI Pharma to develop OBI-3424 (previously TH-3424) as a potential treatment of cancers expressing AKR1C3

OBI Pharma, Inc., a Taiwan biopharma company announced an agreement with Threshold Pharmaceuticals, Inc. to acquire TH-3424, a first-in-class novel small-molecule prodrug that selectively...

Organs-On-Chips To Revolutionize The Drug Development Industry

The market for organs-on-chips (OOCs), the cell culture chips that imitate the activities, mechanisms and responses of organs, will be worth $284 millionby 2021,...

Beactica announces glioblastoma research collaboration with Uppsala University and the DDD Platform at SciLifeLab

Beactica AB, the Swedish drug discovery company announced a new research collaboration with Uppsala University and the Drug Discovery and Development Platform at SciLifeLab...

InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery

InMed Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies announced the filing of a provisional...

Aptar Pharma Partners with Kali Care to Develop Real-Time Medication Management Technology

Aptar Pharma and Kali Care have announced that they entered into a partnership in order to address the challenge of monitoring adherence in ophthalmic clinical...

Top Loading Autoclaves for Labs on a Budget

The QCS EV 100 litre top loading autoclave is among the most space-efficient sterilisers available and will appeal to lab managers for their superior...

Establishing a high throughput screen of drug solubility in pharmaceutical excipients

At the discovery and early stages of drug development, the aim is to evaluate the pharmacology, pharmacokinetics and toxicology of a compound using a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read